2.7.1.91: sphingosine kinase
This is an abbreviated version!
For detailed information about sphingosine kinase, go to the full flat file.
Word Map on EC 2.7.1.91
-
2.7.1.91
-
sphingosine-1-phosphate
-
1-phosphate
-
sphingolipids
-
ceramide
-
endothelial
-
sirnas
-
necrosis
-
agonist
-
metastasis
-
artery
-
erk
-
phospholipase
-
fingolimod
-
fibrosis
-
lymphocyte
-
protein-coupled
-
sphingomyelinase
-
tnf
-
pulmonary
-
leukemia
-
sphingomyelin
-
anti-apoptotic
-
s1p-induced
-
stat3
-
pertussis
-
mapks
-
pro-apoptotic
-
mitogen
-
sclerosis
-
pkc
-
rheostat
-
signal-regulated
-
caspase-3
-
pro-survival
-
platelet-derived
-
lysophospholipids
-
cardioprotective
-
phytosphingosine
-
drug development
-
lymphopenia
-
egress
-
glucosylceramide
-
medicine
-
fumonisins
-
s1p-mediated
-
dihydroceramide
-
mitogenesis
-
pdgf-induced
-
ceramide-induced
-
lysophosphatidic
-
fcepsilonri
- 2.7.1.91
- sphingosine-1-phosphate
- 1-phosphate
- sphingolipids
- ceramide
- endothelial
- sirnas
- necrosis
- agonist
- metastasis
- artery
- erk
- phospholipase
- fingolimod
- fibrosis
- lymphocyte
-
protein-coupled
- sphingomyelinase
- tnf
- pulmonary
- leukemia
- sphingomyelin
-
anti-apoptotic
-
s1p-induced
- stat3
- pertussis
- mapks
-
pro-apoptotic
-
mitogen
- sclerosis
- pkc
-
rheostat
-
signal-regulated
- caspase-3
-
pro-survival
-
platelet-derived
- lysophospholipids
-
cardioprotective
- phytosphingosine
- drug development
- lymphopenia
-
egress
- glucosylceramide
- medicine
- fumonisins
-
s1p-mediated
- dihydroceramide
-
mitogenesis
-
pdgf-induced
-
ceramide-induced
-
lysophosphatidic
- fcepsilonri
Reaction
Synonyms
dihydrosphingosine kinase, kinase, dihydrosphingosine (phosphorylating), kinase, sphingosine (phosphorylating), More, SGK, SK, SK-1, SK-2, SK1, SK2, sphinganine kinase, sphingoid base kinase, sphingosine kinase, sphingosine kinase 1, sphingosine kinase 2, sphingosine kinase type 1, sphingosine kinase type 2, sphingosine kinase-1, sphingosine kinase-2, SPHK, SPHK-1, SPHK1, SPHK1a, SPHK1b, SPHK2, SPK
ECTree
Advanced search results
KI Value
KI Value on EC 2.7.1.91 - sphingosine kinase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
0.000047 - 0.0042
(2S)-1-(4-[4-[3-(2-cyclohexylethyl)phenyl]-1,3-oxazol-2-yl]benzoyl)pyrrolidine-2-carboximidamide
-
0.000075 - 0.003
(2S)-1-[3-[7-(cyclohexylmethoxy)heptyl]benzoyl]pyrrolidine-2-carboximidamide
-
0.00009 - 0.00012
(2S)-2-([3-[4-([4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino)phenyl]-1,2,4-oxadiazol-5-yl]methyl)pyrrolidine-1-carboximidamide
-
0.000089 - 0.0065
(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
-
0.00037
(2S)-2-[3-[4-(octyloxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.00102 - 0.0038
(2S)-2-[3-[6-(hexyloxy)naphthalen-2-yl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
-
0.00098
(2S)-2-[3-[6-(pentyloxy)naphthalen-2-yl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.00098
(2S,3S)-3-hydroxy-2-[3-[6-(2-methylpropoxy)naphthalen-2-yl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.0009
(2S,3S)-3-hydroxy-2-[3-[6-(pentyloxy)naphthalen-2-yl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.0064
(5Z)-3-(2-aminoethyl)-5-[3-(4-butoxyphenyl)propylidene]-1,3-thiazolidine-2,4-dione
-
0.083 - 0.1
(R)-amino(2-((4-decylphenyl)carbamoyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
0.088 - 0.096
(R)-amino(3-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-pyrrolidin-1-yl)methaniminium
0.000197
(S)-2-(3-(3-(tert-butyl)-4-((4-(trifluoromethyl)benzyl)-oxy)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.000089
(S)-2-(3-(3-(trifluoromethyl)-4-((4-(trifluoromethyl)-benzyl)oxy)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.000186
(S)-2-(3-(3-cyclopropyl-4-((4-(trifluoromethyl)-benzyl)oxy)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.000192
(S)-2-(3-(3-isopropyl-4-((4-(trifluoromethyl)benzyl)-oxy)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.000201
(S)-2-(3-(3-propyl-4-((4-(trifluoromethyl)benzyl)oxy)-phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.042 - 0.096
(S)-2-(5-(4-octylphenyl)-1,3,4-oxadiazol-2-yl)pyrrolidin-1-ium 2,2,2-trifluoroacetate
0.085 - 0.094
(S)-amino((2-hydroxy-1-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)ethyl)amino)methaniminium
0.012 - 0.075
(S)-amino(2-((3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-methyl)pyrrolidin-1-yl)methaniminium chloride
0.091 - 0.1
(S)-amino(2-((4-decylphenyl)carbamoyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
0.09 - 0.095
(S)-amino(2-((4-octylbenzamido)methyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
0.095 - 0.1
(S)-amino(2-((4-octylbenzyl)carbamoyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
0.077 - 0.08
(S)-amino(2-(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-ethyl)pyrrolidin-1-yl)methaniminium
0.1
(S)-amino(2-(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-ethyl)pyrrolidin-1-yl)methaniminium chloride
pH and temperature not specified in the publication
0.09 - 0.094
(S)-amino(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-2,5-di-hydro-1H-pyrrol-1-yl)methaniminium 2,2,2-trifluoroacetate
0.056 - 0.098
(S)-amino(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-piperidin-1-yl)methaniminium
0.091 - 0.095
(S)-amino(2-(5-(4-octylphenyl)-1,2,4-oxadiazol-3-yl)-pyrrolidin-1-yl)methaniminium
0.075
1-((3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)methyl)guanidine
pH and temperature not specified in the publication
0.0001 - 0.0103
1-[3-(3-decylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.00004 - 0.0141
1-[3-(3-dodecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.00098 - 0.0117
1-[3-(3-tridecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.00007 - 0.0099
1-[3-(3-undecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.00044 - 0.006
1-[3-(4-decylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.00032 - 0.008
1-[3-(4-dodecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.0025 - 0.011
1-[3-(4-tridecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.043 - 0.055
1-[3-(4-undecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
-
0.0004 - 0.0102
1-[5-(3-dodecylphenyl)-1,2,4-oxadiazol-3-yl]cyclopropane-1-carboximidamide
-
0.0002 - 0.0081
1-[5-(3-dodecylphenyl)-1,3,4-oxadiazol-2-yl]cyclopropane-1-carboximidamide
-
0.003 - 0.0034
1-[5-(4-dodecylphenyl)-1,2,4-oxadiazol-3-yl]cyclopropane-1-carboximidamide
-
0.0012 - 0.0016
1-[5-(4-dodecylphenyl)-1,3,4-oxadiazol-2-yl]cyclopropane-1-carboximidamide
-
0.0093
5-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)tricyclo[3.3.1.13,7]decane-2-carboxamide
pH not specified in the publication, temperature not specified in the publication
0.0031 - 0.0042
5-(4-chlorophenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]tricyclo[3.3.1.13,7]decane-2-carboxamide
0.00002
Amgen 82
isoform SphK2, pH and temperature not specified in the publication
-
0.069 - 0.092
amino((1S,3S)-3-hydroxy-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl)methaniminium
0.07 - 0.096
amino((1S,4S)-4-hydroxy-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl)methaniminium
0.065 - 0.098
amino((2S,4R)-4-hydroxy-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl)methaniminium
0.00028
N-(3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-cyclohexylacetamide
pH not specified in the publication, temperature not specified in the publication
0.055
N-[(2S)-1-amino-1-iminopropan-2-yl]-3-octylbenzamide
isoform SphK1, pH and temperature not specified in the publication
-
0.016
SLP-120701
IC50 above 100 mM, isoform SphK2, at pH 8.0 and 25°C
-
0.0014
SLR080811
isoform SphK2, pH and temperature not specified in the publication
0.000125
isoform SphK1, pH and temperature not specified in the publication
-
0.0015
(2S)-1-(3-dodecylbenzoyl)pyrrolidine-2-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.000047
isoform SphK1, pH and temperature not specified in the publication
-
0.0042
(2S)-1-(4-[4-[3-(2-cyclohexylethyl)phenyl]-1,3-oxazol-2-yl]benzoyl)pyrrolidine-2-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.000075
isoform SphK1, pH and temperature not specified in the publication
-
0.003
(2S)-1-[3-[7-(cyclohexylmethoxy)heptyl]benzoyl]pyrrolidine-2-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.00009
(2S)-2-([3-[4-([4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino)phenyl]-1,2,4-oxadiazol-5-yl]methyl)pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.00012
(2S)-2-([3-[4-([4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino)phenyl]-1,2,4-oxadiazol-5-yl]methyl)pyrrolidine-1-carboximidamide
isoform SphK1, at pH 8.0 and 25°C
-
0.000089
(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
isoform SphK2, at pH 8.0 and 25°C
-
0.0065
(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
isoform SphK1, at pH 8.0 and 25°C
-
0.00102
isoform SphK2, pH and temperature not specified in the publication
-
0.0038
(2S)-2-[3-[6-(hexyloxy)naphthalen-2-yl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.014
pH not specified in the publication, temperature not specified in the publication
0.016
(2S,3R,4E)-2-(dimethylamino)octadec-4-ene-1,3-diol
pH not specified in the publication, temperature not specified in the publication
0.0064
isoform SphK2, at pH 8.0 and 25°C
-
0.0064
(5Z)-3-(2-aminoethyl)-5-[3-(4-butoxyphenyl)propylidene]-1,3-thiazolidine-2,4-dione
isoform SphK2, pH and temperature not specified in the publication
-
0.044
pH and temperature not specified in the publication
0.093
(R)-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide
pH and temperature not specified in the publication
0.083
pH and temperature not specified in the publication
0.1
(R)-amino(2-((4-decylphenyl)carbamoyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
pH and temperature not specified in the publication
0.088
pH and temperature not specified in the publication
0.096
(R)-amino(3-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-pyrrolidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.078
pH and temperature not specified in the publication
0.09
(S)-1-(1-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)ethyl)-guanidine
pH and temperature not specified in the publication
0.07
pH and temperature not specified in the publication
0.094
(S)-1-(2-methyl-1-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-propyl)guanidine
pH and temperature not specified in the publication
0.092
pH and temperature not specified in the publication
0.096
(S)-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)azetidine-1-carboximidamide
pH and temperature not specified in the publication
0.088
pH and temperature not specified in the publication
0.098
(S)-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidine-1-carboximidamide
pH and temperature not specified in the publication
0.042
pH and temperature not specified in the publication
0.096
(S)-2-(5-(4-octylphenyl)-1,3,4-oxadiazol-2-yl)pyrrolidin-1-ium 2,2,2-trifluoroacetate
pH and temperature not specified in the publication
0.085
pH and temperature not specified in the publication
0.094
(S)-amino((2-hydroxy-1-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)ethyl)amino)methaniminium
pH and temperature not specified in the publication
0.012
pH and temperature not specified in the publication
0.075
(S)-amino(2-((3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-methyl)pyrrolidin-1-yl)methaniminium chloride
pH and temperature not specified in the publication
0.091
pH and temperature not specified in the publication
0.1
(S)-amino(2-((4-decylphenyl)carbamoyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
pH and temperature not specified in the publication
0.09
pH and temperature not specified in the publication
0.095
(S)-amino(2-((4-octylbenzamido)methyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
pH and temperature not specified in the publication
0.095
pH and temperature not specified in the publication
0.1
(S)-amino(2-((4-octylbenzyl)carbamoyl)pyrrolidin-1-yl)-methaniminium 2,2,2-trifluoroacetate
pH and temperature not specified in the publication
0.077
pH and temperature not specified in the publication
0.08
(S)-amino(2-(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-ethyl)pyrrolidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.09
(S)-amino(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-2,5-di-hydro-1H-pyrrol-1-yl)methaniminium 2,2,2-trifluoroacetate
pH and temperature not specified in the publication
0.094
(S)-amino(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-2,5-di-hydro-1H-pyrrol-1-yl)methaniminium 2,2,2-trifluoroacetate
pH and temperature not specified in the publication
0.056
pH and temperature not specified in the publication
0.098
(S)-amino(2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)-piperidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.091
pH and temperature not specified in the publication
0.095
(S)-amino(2-(5-(4-octylphenyl)-1,2,4-oxadiazol-3-yl)-pyrrolidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.088
pH and temperature not specified in the publication
0.099
1-(1-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)cyclopropyl)-guanidine
pH and temperature not specified in the publication
0.0003
isoform SphK1, pH and temperature not specified in the publication
-
0.006
1-carbamimidoyl-N-(3-dodecylphenyl)cyclopropane-1-carboxamide
isoform SphK2, pH and temperature not specified in the publication
-
0.09
pH and temperature not specified in the publication
0.098
1-methyl-1-((3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)methyl)-guanidine
pH and temperature not specified in the publication
0.0001
isoform SphK1, pH and temperature not specified in the publication
-
0.0103
1-[3-(3-decylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.00004
isoform SphK1, pH and temperature not specified in the publication
-
0.0141
1-[3-(3-dodecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.00098
isoform SphK1, pH and temperature not specified in the publication
-
0.0117
1-[3-(3-tridecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.00007
isoform SphK1, pH and temperature not specified in the publication
-
0.0099
1-[3-(3-undecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.00044
isoform SphK1, pH and temperature not specified in the publication
-
0.006
1-[3-(4-decylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.00032
isoform SphK1, pH and temperature not specified in the publication
-
0.008
1-[3-(4-dodecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.0025
isoform SphK1, pH and temperature not specified in the publication
-
0.011
1-[3-(4-tridecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.043
isoform SphK2, pH and temperature not specified in the publication
-
0.055
1-[3-(4-undecylphenyl)-1,2,4-oxadiazol-5-yl]cyclopropane-1-carboximidamide
isoform SphK1, pH and temperature not specified in the publication
-
0.0004
isoform SphK1, pH and temperature not specified in the publication
-
0.0102
1-[5-(3-dodecylphenyl)-1,2,4-oxadiazol-3-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.0002
isoform SphK1, pH and temperature not specified in the publication
-
0.0081
1-[5-(3-dodecylphenyl)-1,3,4-oxadiazol-2-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.003
isoform SphK1, pH and temperature not specified in the publication
-
0.0034
1-[5-(4-dodecylphenyl)-1,2,4-oxadiazol-3-yl]cyclopropane-1-carboximidamide
isoform SphK2, pH and temperature not specified in the publication
-
0.0012
isoform SphK2, pH and temperature not specified in the publication
-
0.0016
1-[5-(4-dodecylphenyl)-1,3,4-oxadiazol-2-yl]cyclopropane-1-carboximidamide
isoform SphK1, pH and temperature not specified in the publication
-
0.0079
pH not specified in the publication, temperature not specified in the publication
0.016
2-(4-hydroxyanilino)-4-(4-chlorophenyl)thiazole
pH not specified in the publication, temperature not specified in the publication
0.017
2-(4-hydroxyanilino)-4-(4-chlorophenyl)thiazole
pH 7.4, 30°C, competitive inhibition
0.048
2-(4-hydroxyanilino)-4-(4-chlorophenyl)thiazole
pH 7.4, 30°C, uncompetitive inhibition
0.0031
pH not specified in the publication, temperature not specified in the publication
0.0042
5-(4-chlorophenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]tricyclo[3.3.1.13,7]decane-2-carboxamide
pH not specified in the publication, temperature not specified in the publication
0.069
pH and temperature not specified in the publication
0.092
amino((1S,3S)-3-hydroxy-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.07
pH and temperature not specified in the publication
0.096
amino((1S,4S)-4-hydroxy-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.065
pH and temperature not specified in the publication
0.098
amino((2S,4R)-4-hydroxy-2-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.084
pH and temperature not specified in the publication
0.09
amino(3-(3-(4-octylphenyl)-1,2,4-oxadiazol-5-yl)azetidin-1-yl)methaniminium
pH and temperature not specified in the publication
0.008
isoform SphK2, at pH 8.0 and 25°C
-
0.06
N,N-dimethyl-4-(3-octylphenyl)-N-propylcyclohexan-1-aminium
isoform SphK1, at pH 8.0 and 25°C
-
0.0002
isoform SphK1, pH and temperature not specified in the publication
-
0.0005
N-(1-carbamimidoylcyclopropyl)-3-dodecylbenzamide
isoform SphK2, pH and temperature not specified in the publication
-
0.0046
isoform SphK1, pH and temperature not specified in the publication
-
0.0109
N-(1-carbamimidoylcyclopropyl)-4-dodecylbenzamide
isoform SphK2, pH and temperature not specified in the publication
-
0.02
isoform SphK2, pH and temperature not specified in the publication
-
0.055
VPC94075
isoform SphK1, pH and temperature not specified in the publication
-